Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

The effect of systemic corticosteroids on the incidence of gastrointestinal bleeding in critically ill adults: a systematic review with meta-analysis

Research output: Contribution to journalReviewResearchpeer-review

  1. Tracheostomy practice and timing in traumatic brain-injured patients: a CENTER-TBI study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Heterogeneity of treatment effect of prophylactic pantoprazole in adult ICU patients: a post hoc analysis of the SUP-ICU trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Lactate versus acetate buffered intravenous crystalloid solutions: a scoping review

    Research output: Contribution to journalReviewResearchpeer-review

  2. Evaluating Non-Statistically Significant Results From Trials in Practice-Reply

    Research output: Contribution to journalComment/debateResearchpeer-review

View graph of relations

PURPOSE: To assess the effect of systemic corticosteroids on the incidence of gastrointestinal bleeding in adult critically ill patients.

METHODS: We systematically reviewed randomised clinical trials comparing systemic corticosteroids administered for more than 24 h with placebo/no treatment in adult critically ill patients. Trial selection, data abstraction and risk of bias assessments were performed in duplicate. We used trial sequential analysis (TSA) to assess the risk of random errors and the grading of recommendations, assessment, development, and evaluations (GRADE) approach to assess the quality of evidence. The primary outcome was the incidence of clinically important gastrointestinal bleeding within 90 days. The secondary outcome was the incidence of gastrointestinal bleeding of any severity within 90 days.

RESULTS: Twenty-five trials (n = 14,615) reported data for the primary outcome and 55 trials (n = 21,792) for the secondary outcome. The pooled incidence of clinically important gastrointestinal bleeding was 2.3% in the corticosteroid group and 1.8% in the control group (RR, 1.26; 95% CI, 1.01-1.57; I2 = 0%, TSA-adjusted CI 0.51-3.14). We observed no difference in the risk of gastrointestinal bleeding of any severity (RR, 1.10; 95% CI, 0.92-1.32; I2 = 0%, TSA-adjusted CI 0.87-1.38). The GRADE quality of evidence was low (risk of bias and imprecision).

CONCLUSIONS: We observed an overall low incidence of clinically important gastrointestinal bleeding among adult critically ill patients. Corticosteroids may slightly increase the incidence of clinically important gastrointestinal bleeding, but not bleeding of any severity. Rarity of events, infrequent trial reporting and high risk of bias reduced the quality of evidence.

Original languageEnglish
JournalIntensive Care Medicine
Volume45
Issue number11
Pages (from-to)1540-1549
Number of pages10
ISSN0342-4642
DOIs
Publication statusPublished - Nov 2019

    Research areas

  • Corticosteroids, Critical illness, Gastrointestinal bleeding, Intensive care unit, Peptic ulcer disease, Steroids, Systematic review

ID: 58598845